OWC Pharmaceutical Research Corp Forecast and Stock Analysis
Technical OWCP stock analysis for February 15, 2019.
OWC Pharmaceutical Research Corp fell by -6.42% in the last day from $0.06 to $0.05 The price has fallen in 6 of the last 10 days and is down by -48.53% for this period. Volume has increased in the last day by 1.46 million shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 1.46 million shares bought and sold for approximately $76 828.60.
Close price at the end of the last trading day (Friday, 15th Feb 2019) of the OWCP stock was $0.05. This is 6.42% less than the trading day before Thursday, 14th Feb 2019.
During day the stock fluctuated 37.60% from a day low at $0.05 to a day high of $0.07.
30 day high of the OWCP stock price was $0.13 and low was $0.04.
90 day high was $0.19 and low was $0.04.
52 week high for the OWC Pharmaceutical Research Corp - $0.50 and low - $0.04.
OWC Pharmaceutical Research Corp lies in the lower of a very wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $0.04 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -38.70% during the next 3 months and, with 90% probability hold a price between $0.03 and $0.08 at the end of this period.
There are few to none technical positive signals at the moment. OWC Pharmaceutical Research Corp holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.06 and $0.11. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday February 14, 2019, which indicates further falls until a new bottom pivot has been found. OWC Pharmaceutical Research Corp gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's". The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
RSI14 is 13 and the stock is extremely oversold on RSI14, but some stocks may continue to fall despite the high chance of a correction up. The low RSI lowers the general risk and the stock should be considered if other technical requirements like liquidity and risk-reward are meet.
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $0.05 and $0.05.
With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $0.00 may give a huge drop in the stock price.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.02 between high and low, or 37.60%. For the last week, the stock has had a daily average volatility of 23.50%.
OWC Pharmaceutical Research Corp is overbought on RSI14 (13). Some stocks may go long and hard while being overbought on RSI, but overbought increases the general risk as higher volatility could be expected, and at some level the stock will have a reaction back to gain new strength.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
OWC Pharmaceutical Research Corp holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.